- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00138645
The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet (FORMULA)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In recent decades, the prevalence of overweight and obesity has increased dramatically in developed countries. Obesity is associated with diseases such as diabetes, cardiovascular disease, hypertension, and certain cancers. Modest amounts of weight loss (e.g., 5% to 10% of initial body weight) significantly improve health and improve disease status. Recent evidence suggests that the use of supplements or meal replacements promotes greater weight loss than isocaloric food-based diets. In addition, diets that are high in protein are associated with greater ratings of satiety and reduced food intake, as well as greater weight loss, compared to lower protein diets.
The purpose of the proposed study is to test the effect of a partial supplement diet on body weight, body composition, and biomarkers for disease compared to an isocaloric diet that consists of a traditional food-based meal plan. Overweight and obese (BMI 25 to 35) participants will participate in this six-month study. The primary outcome variable is body weight loss and the secondary outcome variables include body composition, blood pressure, lipids, and subjective ratings of satiety.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female gender; of all ethnic backgrounds.
- Healthy person who has not been diagnosed with diabetes, cardiovascular illness, renal, hepatic or other chronic diseases
- > 17 years and < 66 years of age
- Body mass index (BMI; kg/m2) between 25 and 35
For females with the potential to bear children, they meet one of the following criteria:
- They are willing to use an acceptable method of birth control (e.g., oral contraceptive tablets, implanted contraceptive hormones, Depo-Provera® contraceptive injections, intrauterine devices, prophylactic condoms with spermicide, contraceptive diaphragms with spermicide, cervical caps with spermicide), or are in a monogamous relationship with a partner who has had a vasectomy.
- They are sexually abstinent and intend to continue this practice, at least for the duration of the study.
Exclusion Criteria:
- > 65 years and < 18 years of age
- Regular use of medications other than birth control, vitamins or hormone replacement therapy
- Diabetes mellitus (fasting blood sugar [FBS] > 126); persons with impaired glucose tolerance (FBS 100-125) may be admitted to the study.
- Use of tobacco products
- Depression or mental illness requiring treatment or medication within the last six months
- For women, pregnancy, breast feeding, postpartum < 6 months, planning a pregnancy during the study, or are not using an acceptable method of contraception
- Use of medications or herbal supplements that affect appetite or body weight for the previous three months
- Patients requiring restriction of protein intake
- Impaired kidney function (creatinine > 1.5) or liver function (liver enzymes > 3 times the upper limits of normal)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: MicroDiet
Participants randomized to the MicroDiet group (1200 kcal/day) will be instructed by a Registered Dietitian to consume (one shake and 3 cookies; 240 kcal) for two meals each day for Months 1 through 3.
They will be provided with meal plans for the meal that they do not replace with MicroDiet.
During Months 4 through 6, participants in the MicroDiet group will be instructed to replace one meal per day with MD (the energy content of the meal plan will still be 1200 kcal/day).
Participants will also be encouraged to eat or drink MD for snacks.
The rest of the diet will consist of healthy foods, as outlined above.
To help participants adhere to the MicroDiet regimen, they will meet with a registered dietitian for one hour at Week 0 and 30 minutes at Weeks 2 and 4, and every month thereafter.
|
MicroDiet
|
ACTIVE_COMPARATOR: Healthy Diet
Participants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet.
The Healthy Diet will consist of the same foods that are used in the meal plans for the MicroDiet group.
The Healthy Diet group will be instructed not to use meal replacements such as shakes (e.g., Slim Fast®), nutrition bars (e.g., Balance Bar®), or portion-controlled meals (e.g., Healthy Choice entrees).
|
Participants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet but will be instructed not to use meal replacements
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Weight Loss (kg and Percent) at Months 3 and 6
Time Frame: April 2005 to May 2006
|
April 2005 to May 2006
|
|
Percent Change in Body Weight (Completers).
Time Frame: 24 weeks
|
Percent change in body weight from baseline to week 24(completers).
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Body Composition at Months 3 and 6
Time Frame: April 2005 to May 2006
|
April 2005 to May 2006
|
Disease Biomarkers (Cholesterol, Triglycerides, Etc.) at Months 3 and 6
Time Frame: April 2005 to May 2006
|
April 2005 to May 2006
|
Subjective Ratings of Appetite at Week 2 and Months 1, 2, 3, 4, 5, and 6
Time Frame: April 2005 to May 2006
|
April 2005 to May 2006
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC 25004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Weight Changes
-
Pusan National University HospitalCompletedWeight Change, Body
-
Chiang Mai UniversityCompleted
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Washington University School of MedicineCompleted
-
Washington University School of MedicineCompletedWeight ChangeUnited States
-
Hacettepe UniversityCompleted
-
University Hospital Center of MartiniqueRecruiting
-
Huashan HospitalNot yet recruitingWeight Change, BodyChina
-
University of PittsburghTerminatedWeight Loss | Motor ActivityUnited States
-
Instituto de Investigación Hospital Universitario...CompletedObesity | Overweight | Weight Loss | Body Weight Changes | Weight Change, BodySpain